Latest It Consulting News

The Federal Court has approved the transfer of Centrex Limited’s shares to PRL Global, marking the end of Centrex’s external administration and a new chapter as a PRL subsidiary.

The ASX has formally warned Truscott Mining Corporation that its current operations may not meet listing requirements, giving the company six months to demonstrate compliance or face suspension.

NRW Holdings reported a 12.2% revenue increase to $3.27 billion in FY25, offset by a significant impairment linked to OneSteel receivables. The company declared a final fully franked dividend of 9.5 cents per share, underscoring confidence despite challenges.

PointsBet Holdings Limited has lodged its Target’s Statement advising shareholders to reject the unsolicited all-scrip takeover offer from betr Entertainment Limited, endorsing instead the competing all-cash bid from MIXI Australia. The PointsBet Board highlights significant concerns over betr’s offer, including valuation, liquidity, and conditionality.

Titan Minerals has revealed significant new gold and silver mineralisation extensions at its Dynasty Gold Project in Ecuador, boosting prospects for resource growth and mine development.

Lion Rock Minerals confirms exceptionally pure rutile nuggets at its Minta Rutile Project in Cameroon, with independent verification supporting broad titanium industry applications. Exploration results reveal a growing mineralised footprint exceeding 2,750 km², positioning Minta as a globally significant rutile province.

Pengana International Equities is set to diversify its portfolio by adding global private credit exposure, aiming to increase earnings and fully franked dividends by 56%, with monthly payments starting November 2025.

Pengana International Equities reported a solid $33.8 million profit for FY2025 and unveiled a strategic plan to diversify into global private credit, aiming to increase dividends by over half and shift to monthly payments.

Janison Education Group reported a 9% revenue increase to $46.8 million for FY2025, yet its net loss widened by 40%, underscoring ongoing profitability challenges.

Genetic Technologies Limited has emerged from voluntary administration following a strategic asset sale and is now pursuing recapitalisation and acquisitions to restore its market position.

Invion Limited has disclosed that the US FDA granted Orphan Drug Designation for its lead cancer drug candidate INV043, explaining recent unusual trading activity in its shares. The company confirmed it was unaware of the FDA decision prior to its public release and has now complied with continuous disclosure rules.

Duxton Farms has received Foreign Investment Review Board approval for its strategic merger and updated its timetable for key shareholder and court approvals, alongside a $4.55 million capital raise.